Basic & Translational Research

Gut microbes may be responsible for activating the T-cells that cause autoimmune uveitis

Can amniotic stem cells suppress pathologic retinal neovascularization?

Across medicine, far fewer clinical trials report positive results these days. Whether the demise of sharp scientific practices or the lack of low-hanging fruit – does it apply to ophthalmology?

Looking at vitreous samples allows us to determine which proteins are involved in the disease process, and to what degree

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Can the combination of 360° haptics and a novel protective membrane, which emulates the pattern found on shark skin, in a single IOL prevent PCO and make YAG laser capsulotomies a thing of the past?

Sitting Down With… Joan Miller, Chief and Chair of the Department of Ophthalmology, Massachusetts Eye and Ear, Mass General Hospital and Harvard Medical School

Stem cell therapies may be the future of treating retinal disease, but how do you choose the best source?

Unicellular planktonic organisms have evolved a complex eye-like structure by repurposing organelles within the cell